<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>


<title>aktiencheck.de - Forum - Wyeth</title>
<link>http://www.aktiencheck.de</link>
<description>aktiencheck.de</description>
<language></language>
<copyright>aktiencheck.de</copyright>
<lastBuildDate>Sat, 25 Apr 2026 10:40:15 +0200</lastBuildDate>
<ttl>2</ttl>








<item>
<title>WYE</title>
<link>http://www.aktiencheck.de/forum/WYE-850229-t305434</link>
<guid>http://www.aktiencheck.de/forum/WYE-850229-t305434</guid>
<description>WYE, Wyeth (WYE US): The company's new menopause pill, combining the hormone estrogen with a bone-loss remedy, reduced hot flashes by 80 percent in a study, suggesting it will be doctors' first choice if approved by U.S. regulators, according to results presented at a medical meeting in Dallas. Wyeth said it intends to file for U.S. marketing approval for the drug, called Aprela, in the second quarter. The stock rose $1.10 to $47.69 in regular trading. [&lt;a href=&#034;http://www.aktiencheck.de/forum/WYE-850229-t305434&#034;&gt;mehr&lt;/a&gt;]</description>
</item>

</channel>
</rss>







